Journal of Clinical Oncology

Chemoradiotherapy in Pancreatic Cancer: Toward Precision Oncology

J Jian Xu G Guo Wu (Jian Xu, MD; Guo Wu, MD; and Jingdong Li, MD, PhD, Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepatobiliary-Pancreatic-Intestinal Diseases of North Sichuan Medical College, Nanchong, China; and National Clinical Key Specialty (General Surgery), Sichuan Branch of National Clinical Research Center for Digestive Diseases, Nanchong, China) J Jingdong Li (Jian Xu, MD; Guo Wu, MD; and Jingdong Li, MD, PhD, Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepatobiliary-Pancreatic-Intestinal Diseases of North Sichuan Medical College, Nanchong, China; and National Clinical Key Specialty (General Surgery), Sichuan Branch of National Clinical Research Center for Digestive Diseases, Nanchong, China)
View Original
APA MLA Chicago BibTeX RIS

Article Details

Volume / Issue Vol. 44, Issue 20
Published July 10, 2026
Pages 1947-1949
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences

Authors (3)

J

Jian Xu

G

Guo Wu

Jian Xu, MD; Guo Wu, MD; and Jingdong Li, MD, PhD, Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepatobiliary-Pancreatic-Intestinal Diseases of North Sichuan Medical College, Nanchong, China; and National Clinical Key Specialty (General Surgery), Sichuan Branch of National Clinical Research Center for Digestive Diseases, Nanchong, China

J

Jingdong Li

Jian Xu, MD; Guo Wu, MD; and Jingdong Li, MD, PhD, Department of Hepatobiliary Surgery, Affiliated Hospital of North Sichuan Medical College, Nanchong, China; Institute of Hepatobiliary-Pancreatic-Intestinal Diseases of North Sichuan Medical College, Nanchong, China; and National Clinical Key Specialty (General Surgery), Sichuan Branch of National Clinical Research Center for Digestive Diseases, Nanchong, China

Related Articles from this Journal

Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Ismaela Anna Vascotto, Filippo Antonica et al. Aug 2026 10.1200/jco-26-00658

Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial

Samer A. Srour, Jad Chahoud et al. Aug 2026 10.1200/jco-26-00388

Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection

Risako Komata, Kenju Ando et al. Aug 2026 10.1200/jco-26-00140

Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)

Ghayas C. Issa, Branko Cuglievan et al. Aug 2026 10.1200/jco-26-01743

Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer

Irbaz Bin Riaz, R. Bryan Rumble et al. Aug 2026 10.1200/jco-26-01001